Hikma Pharmaceuticals
HIK.L
#3281
Rank
HK$36.45 B
Marketcap
HK$176.12
Share price
2.57%
Change (1 day)
9.21%
Change (1 year)

EPS for Hikma Pharmaceuticals (HIK.L)

EPS in 2019 (TTM): N/A

In 2022 the company made an earnings per share (EPS) of HK$6.58 a decrease over its 2021 EPS that were of HK$14.30.

EPS history for Hikma Pharmaceuticals from 2002 to 2019

Annual EPS

Year EPS Change
2022HK$6.58-53.98%
2021HK$14.30-0.16%
2020HK$14.33-9.06%
2019HK$15.7571.62%
2018HK$9.18-133.3%
2017-HK$27.56-628.27%
2016HK$5.22-47.47%
2015HK$9.93-9.83%
2014HK$11.0230.48%
2013HK$8.44110.57%
2012HK$4.0123.73%
2011HK$3.24-19.65%
2010HK$4.0325.67%
2009HK$3.2134.54%
2008HK$2.39-17.84%
2007HK$2.9013.5%
2006HK$2.568.67%
2005HK$2.35-98.86%
2004HK$206.3424711.32%
2003HK$0.8368.25%
2002HK$0.49